The recognition of aquaporin-4-antibody NMOSD and MOGAD as separate diseases sparked interest in the cohort of patients with NMOSD features and red flags for the diagnosis of MS who are negative for both autoantibodies. Here, AQP4 is linked to myeloid sarcoma.